Latest from Sharemarket

Common sense or overkill? Climate rules loosened by more than expected

The minister suggested a more moderate weakening of climate disclosure rules.

Greg Smith: What 2026 could hold for markets, AI and your KiwiSaver balance

OPINION: How to position your KiwiSaver as markets face another restless year.

Northern winter swings: How flu and tariffs could hit F&P Healthcare revenue

Northern Hemisphere flu hospitalisations can move FPH revenue by about 5%.

Wall St bets on fourth year of gains as S&P 500 bull run rolls into 2026

All 21 Wall Street strategists surveyed tip the S&P 500 to rise in 2026.

Mark Lister: How a turbulent 2025 set the stage for investors’ moves in 2026

OPINION: World shares swung from a 16.3% slump to a 35% surge, ending 2025 strongly.

Stock Takes: BlackRock still 'pro-risk' despite talk of AI bubble

BlackRock's unrelenting 'pro-risk' approach, and Vital management goes internal.

Editorial: Who's watching the watchdog? Cloud over FMA chair undermines trust

OPINION: The investigation comes at the worst time for the FMA.

Market close: Retirement stocks rise on quiet day for NZ sharemarket

The NZX was up slightly with Ryman and Summerset benefiting from a lull.

Mark Lister: Why NZ's market isn't really at a record high

OPINION: When dividends are stripped out, the NZX 50 remains 13.9% below its 2021 peak.

Liam Dann: What Labubus tell us about today’s market mania

OPINION: Nvidia's latest result had market-watchers holding their breath.

Revenue down, profit up for Oceania after expenses cut

The $150m Helier opened in 2023, was 69% empty in 2024 but that has dropped to 45% now.

Stock Takes: Could F&P Healthcare surprise with better than forecast result?

F&P Healthcare has forecast revenue of $1.075b and net profit of $200m for the half.

Argosy profit nearly doubles as chairman backs quake reform

Government reforms will reduce unnecessary compliance costs, CEO Peter Mence says.

Markets slide as Nvidia test looms and Fed doubts grow

Nvidia shares fell 1.9% ahead of its earnings, testing investor confidence.

Why Xero shares are tumbling despite record profit, bullish outlook

The $4b elephant in the room, 'exhausted pricing power', slowing growth, an AI poser.

Stock Takes: Why this reporting season could signal a long-awaited economic rebound

About 20-odd companies are due to report results over the next few weeks.